Trial Profile
BeSt for kids: A randomized clinical trial to test the effectiveness of different treatment strategies in patients with Juvenile Idiopathic Arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2018
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate (Primary) ; Prednisone (Primary) ; Sulfasalazine (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms BeSt for kids
- 07 Nov 2018 Status changed to completed.
- 07 May 2009 New trial record